Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05977881 · ClinicalTrials.gov registry record · NA

Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study

A NA study of HIV Infections, sponsored by Johns Hopkins Bloomberg School of Public Health.

Recruiting
Registry status
NA
Development phase
500
Enrollment target
1
Study location

NCT05977881 is a NA study of HIV Infections that is actively recruiting participants, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 500 participants, above the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (12% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05977881, a NA study of HIV Infections, is actively recruiting participants, sponsored by Johns Hopkins Bloomberg School of Public Health.

RECRUITING
Registry status
NA
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

Through the proposed Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement (SCOPE) study, the investigators will design and evaluate an overdose prevention and HIV prevention study among people who use drugs (PWUD). Specifically, SCOPE will provide access to drug-checking services for PWUD to better understand the contents of the drug supply, in combination with PrEP for those who are HIV-, to both reduce overdose and HIV among PWUD in Baltimore City.

Conditions Studied

HIV Infections

Interventions

  • OTHER CHECKIT!

Study Locations (1)

Maryland

  • Johns Hopkins School of Public Health - Baltimore

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2023-07-28
Est. Completion 2026-06-30
Phase NA

Sponsor

Johns Hopkins Bloomberg School of Public Health

187 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05977881

The ClinicalTrials.gov registry entry for NCT05977881 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (12% higher). The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which CHECKIT! is the first listed.

NCT05977881 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT05977881 about?

NCT05977881 is a clinical study titled "Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study". Through the proposed Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement (SCOPE) study, the investigators will design and evaluate an overdose prevention and HIV prevention study among people who use drugs (PWUD). Specifically, SCOPE will provide access to drug-checking servic...

What is the current status of trial NCT05977881?

This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2023-07-28. Estimated completion is 2026-06-30.

What conditions does trial NCT05977881 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT05977881?

The interventions under investigation include: CHECKIT! (OTHER).

Who is sponsoring clinical trial NCT05977881?

This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05977881 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.